Free Trial

Dimensional Fund Advisors LP Has $105 Million Holdings in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Dimensional Fund Advisors LP boosted its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 14.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,406,592 shares of the health services provider's stock after acquiring an additional 177,075 shares during the period. Dimensional Fund Advisors LP owned 2.46% of Maximus worth $105,001,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in Maximus by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after buying an additional 205,564 shares during the last quarter. Van Berkom & Associates Inc. increased its holdings in shares of Maximus by 8.5% in the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after acquiring an additional 98,264 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Maximus by 7.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock valued at $74,700,000 after acquiring an additional 71,598 shares in the last quarter. Norges Bank bought a new position in Maximus during the fourth quarter worth $71,443,000. Finally, Federated Hermes Inc. increased its stake in Maximus by 74.8% during the fourth quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock valued at $65,912,000 after purchasing an additional 377,705 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Insider Transactions at Maximus

In related news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a research report on Thursday, January 2nd.

View Our Latest Analysis on MMS

Maximus Stock Performance

Shares of NYSE:MMS traded up $0.51 during trading hours on Friday, hitting $66.84. The stock had a trading volume of 60,688 shares, compared to its average volume of 555,402. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The stock's fifty day simple moving average is $67.67 and its 200 day simple moving average is $73.97. The firm has a market capitalization of $3.78 billion, a price-to-earnings ratio of 14.36 and a beta of 0.68. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Sell-side analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.80%. Maximus's dividend payout ratio (DPR) is 25.81%.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines